Orion Biotech Opportunities Corp.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ORIA research report →
Price Chart
About the company
Orion Biotech Opportunities Corp. functions as a blank check company, meaning its primary goal is to undertake a business combination – such as a merger, acquisition of assets or shares, or a corporate reorganization – with one or more existing businesses. Established in 2021, the company is headquartered in New York, New York.
- CEO
- Zuie-Chin Huang
- IPO
- 2021
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on ORIA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $0
- P/E
- 11.12
- PEG
- 0.00
- P/S
- 0.00
- P/B
- 1.05
- EV/EBITDA
- 0.03
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 9.66%
- ROIC
- -0.44%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-900,000
- Net Income
- $18.41M+2342.6%
- EPS
- $0.92+2904.9%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $12.00
- 52W Low
- $9.71
- 50D MA
- $10.27
- 200D MA
- $10.05
- Beta
- 0.00
- RSI (14)
- 48
- Avg Volume
- 81.31K
No earnings-call transcripts are available for ORIA yet.
of shares held by institutions
51 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Spring Creek Capital LLC | 800.00K | 0 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 17, 23 | Orion Sponsor Holdings, LLC | sell | 4,879,999 |
| May 17, 23 | Broder Samuel | sell | 40,000 |
| May 17, 23 | Collins James J. | sell | 40,000 |
| May 17, 23 | Rodriguez Louisa | sell | 40,000 |
| Jun 25, 21 | Orion Sponsor Holdings, LLC | other | 750,000 |
| May 12, 21 | Broder Samuel | other | 40,000 |
| May 12, 21 | Simonds Robert Kenneth | other | 0 |
| May 12, 21 | Rodriguez Louisa | other | 40,000 |
| May 12, 21 | Kayal Mark | other | 0 |
| May 12, 21 | Huang James | other | 5,630,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ORIA coverage
Recent articles, reports, and earnings notes.
No research on ORIA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ORIA report →